Gil D. Fine

Consequences of Delayed Treatment Effects on Analysis of Time-to-Event Endpoints

Gil D. Fine · Drug Information Journal · 2007 · 59 citations

Treatment Effect, Randomized Controlled Trial, Time-varying Confounding +6

Decitabine: development of a DNA methyltransferase inhibitor for hematological malignancies.

John F. Lyons, Emel Bayar, Gil D. Fine et al. · PubMed · 2003 · 31 citations

Epigenetic Change, Molecular Biology, Pharmacotherapy +16

A phase I, first-in-human dose-escalation study of amuvatinib, a multi-targeted tyrosine kinase inhibitor, in patients with advanced solid tumors

Raoul Tibes, Gil D. Fine, Gavin Choy et al. · Cancer Chemotherapy and Pharmacology · 2012 · 26 citations

Medicine, Pharmacology, Advanced Solid Tumors +5

Phase I Study of Alvocidib Followed by 7+3 (Cytarabine + Daunorubicin) in Newly Diagnosed Acute Myeloid Leukemia

Joshua F. Zeidner, Daniel J. Lee, Mark G. Frattini et al. · Clinical Cancer Research · 2020 · 25 citations · Full text

Multicenter Phase 1b/2a Clinical Trial of Radioprotectant BIO 300 Oral Suspension for Patients With Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy

Charles B. Simone, Artur A. Serebrenik, Elizabeth Gore et al. · International Journal of Radiation Oncology*Biology*Physics · 2023 · 12 citations · Full text